日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Sorafenib as first-line therapy for metastatic uveal melanoma: A multicenter, placebo-controlled randomized discontinuation study (STREAM)

索拉非尼作为转移性葡萄膜黑色素瘤的一线治疗:一项多中心、安慰剂对照的随机停药研究(STREAM)

Kalkavan, Halime; Scheulen, Max E; Kämpgen, Eckhart; Keilholz, Ulrich; Heinzerling, Lucie; Lueong, Smiths S; Hlinka, Annalena; Gromke, Tanja; Ochsenreither, Sebastian; Hilger, Ralf-Axel; Grubert, Matthias; Wetter, Axel; Guberina, Nika; Zeschnigk, Michael; Ferency, Peter; Held, Swantje; Hinke, Axel; Schuler, Gerold; Al-Ghazzawi, Karim; Bornfeld, Norbert; Bechrakis, Nikolaos E; Schuler, Martin; Bauer, Sebastian; Richly, Heike; Siveke, Jens T

Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapy

基于基因网络和集成模型的肿瘤相关抗原筛选,以预测其组织损伤风险较低,用于靶向免疫治疗。

Lischer, Christopher; Eberhardt, Martin; Flamann, Cindy; Berges, Johannes; Güse, Esther; Wessely, Anja; Weich, Adrian; Retzlaff, Jimmy; Dörrie, Jan; Schaft, Niels; Wiesinger, Manuel; März, Johannes; Schuler-Thurner, Beatrice; Knorr, Harald; Gupta, Shailendra; Singh, Krishna Pal; Schuler, Gerold; Heppt, Markus Vincent; Koch, Elias Andreas Thomas; van Kleef, Nadine D; Freen-van Heeren, Julian J; Turksma, Annelies W; Wolkenhauer, Olaf; Hohberger, Bettina; Berking, Carola; Bruns, Heiko; Vera, Julio

The future of affordable cancer immunotherapy

经济实惠的癌症免疫疗法的未来

Schaft, Niels; Dörrie, Jan; Schuler, Gerold; Schuler-Thurner, Beatrice; Sallam, Husam; Klein, Shiri; Eisenberg, Galit; Frankenburg, Shoshana; Lotem, Michal; Khatib, Areej

A One-Armed Phase I Dose Escalation Trial Design: Personalized Vaccination with IKKβ-Matured, RNA-Loaded Dendritic Cells for Metastatic Uveal Melanoma

一项单臂 I 期剂量递增试验设计:采用 IKKβ 成熟的 RNA 负载树突状细胞进行个性化疫苗接种治疗转移性葡萄膜黑色素瘤

Koch, Elias A T; Schaft, Niels; Kummer, Mirko; Berking, Carola; Schuler, Gerold; Hasumi, Kenichiro; Dörrie, Jan; Schuler-Thurner, Beatrice

Assessment of sorafenib induced changes in tumor perfusion of uveal melanoma metastases with dynamic contrast-enhanced ultrasound (DCE-US)

利用动态对比增强超声(DCE-US)评估索拉非尼诱导的葡萄膜黑色素瘤转移瘤的肿瘤灌注变化

Wildner, Dane; Heinzerling, Lucie; Scheulen, Max E; Kaempgen, Eckhart; Schuler, Gerold; Strobel, Deike; Janka, Rolf; Neurath, Markus F; Sturm, Joerg; Knieling, Ferdinand

Safety and tolerability of a single infusion of autologous ex vivo expanded regulatory T cells in adults with ulcerative colitis (ER-TREG 01): protocol of a phase 1, open-label, fast-track dose-escalation clinical trial

单次输注自体体外扩增的调节性T细胞治疗成人溃疡性结肠炎的安全性和耐受性(ER-TREG 01):一项1期、开放标签、快速剂量递增临床试验方案

Voskens, Caroline J; Stoica, Diane; Roessner, Susanne; Vitali, Francesco; Zundler, Sebastian; Rosenberg, Marita; Wiesinger, Manuel; Wunder, Jutta; Siegmund, Britta; Schuler-Thurner, Beatrice; Schuler, Gerold; Berking, Carola; Atreya, Raja; Neurath, Markus F

Therapeutic Cancer Vaccination with Ex Vivo RNA-Transfected Dendritic Cells-An Update

利用体外RNA转染树突状细胞进行癌症治疗性疫苗接种——最新进展

Dörrie, Jan; Schaft, Niels; Schuler, Gerold; Schuler-Thurner, Beatrice

Blood Eosinophilia is an on-Treatment Biomarker in Patients with Solid Tumors Undergoing Dendritic Cell Vaccination with Autologous Tumor-RNA

血液嗜酸性粒细胞增多症是接受自体肿瘤RNA树突状细胞疫苗治疗的实体瘤患者的治疗中生物标志物。

Moreira, Alvaro; Erdmann, Michael; Uslu, Ugur; Vass, Verona; Schuler, Gerold; Schuler-Thurner, Beatrice

CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor Leukemia

用于治疗高危儿童B细胞前体白血病的CSPG4特异性CAR T细胞

Harrer, Dennis C; Schuler, Gerold; Dörrie, Jan; Schaft, Niels

Arming T Cells with a gp100-Specific TCR and a CSPG4-Specific CAR Using Combined DNA- and RNA-Based Receptor Transfer

利用DNA和RNA联合受体转移技术,使T细胞携带gp100特异性TCR和CSPG4特异性CAR。

Simon, Bianca; Harrer, Dennis C; Schuler-Thurner, Beatrice; Schuler, Gerold; Uslu, Ugur